ARCHIVES

In Brief: NCI To Supply Maytansine For Several Phase I Studies; Holleb Urges Referrals To “Experts”

This article is from The Cancer Letter archive.

Vol. 02 No. 13 | March 26, 1976

Download PDF Visit The Full Archive

Related Articles

ASCO Annual Meeting: New Therapeutic Approaches To Breast Cancer Highlighted

June 25, 2004

Early HER2 Positive Patients At Higher Risk of Recurrence

January 30, 2009

NIH selects nine scientists for Pioneer Awards.

October 1, 2004

Amgen’s Kepivance Approved For Severe Oral Mucositis

January 28, 2005

Many Colorectal Cancer Survivors Do Not Receive Recommended Follow-up Care

September 26, 2008

First “Annual” CCOP RFA Issued; Research Bases Must Compete

June 8, 1990